From gut to kidney: transporting and metabolizing calcineurin-inhibitors in solid organ transplantation.
about
Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantationTolerance in liver transplantation: Biomarkers and clinical relevanceCircadian variation of cytotoxicity and genotoxicity induced by an immunosuppressive agent "Mycophenolate Mofetil" in rats.Systemic meta-analysis assessing the short term applicability of early conversion to mammalian target of rapamycin inhibitors in kidney transplant.Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patientsAssociation of Extrarenal Adverse Effects of Posttransplant Immunosuppression With Sex and ABCB1 Haplotypes.Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients.Variations in Practice to Therapeutic Monitoring of Tacrolimus following Primary Adult Liver TransplantationDrug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting.Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patientsEffect of CYP3A4*22, CYP3A5*3, and CYP3A Combined Genotypes on Cyclosporine, Everolimus, and Tacrolimus Pharmacokinetics in Renal Transplantation.Dosing algorithms for initiation of immunosuppressive drugs in solid organ transplant recipients.Unlocking the Potential of Purinergic Signaling in TransplantationCyclosporine A attenuates apoptosis and necrosis after ischemia-reperfusion-induced renal injury in transiently hyperglycemic rats.Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer.Is Early Conversion to mTOR Inhibitors Represent a Suitable Choice in Renal Transplant Recipients? A Systemic Review of Medium-term OutcomesTacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation.
P2860
Q26751433-B4D3553E-A282-4C0C-92F4-7BE7BD373628Q28079523-2DC55C8E-D287-42A7-96EB-C47E11EDA6E8Q33434301-B0485206-CC27-4A08-AA87-9DC4EA2243A5Q33617408-B8DC8DD6-FE6D-4A2D-B421-FF470D7FF3E2Q34065305-F84550DF-B712-4871-8180-ECC3E808361CQ36256056-D97A70A3-15FD-407A-B582-B2A4DB41288CQ36465101-4F24481E-DA44-411E-ACD5-54B391F0816AQ36587382-19FBF496-F65D-49A2-9E7F-4EEBD81344BCQ36668891-DAEB4BB1-7108-4AF6-8B89-79A1051933F5Q37439873-4A6C9CAA-AAE4-4296-A8B8-74A349DEBFC3Q37620393-0F9C765F-E812-451C-8F0D-23DE8C5490E5Q38417581-6DFF5334-8EF5-43E9-9144-60F38AF54846Q38785475-EB815D11-5D69-4DA0-AD72-B45A2CC19FEBQ38840106-726C847F-4907-4854-9ABF-7DA7C1626153Q40126367-5FE1DDF1-17C5-49EE-BD47-1A1B3235BED9Q41313340-D08CB607-2FBB-45B2-8B2D-DD8BFC3D2C75Q41355218-1E5C1C01-2081-43C4-8E80-66E2E81110BF
P2860
From gut to kidney: transporting and metabolizing calcineurin-inhibitors in solid organ transplantation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
From gut to kidney: transporti ...... n solid organ transplantation.
@en
type
label
From gut to kidney: transporti ...... n solid organ transplantation.
@en
prefLabel
From gut to kidney: transporti ...... n solid organ transplantation.
@en
P2093
P1476
From gut to kidney: transporti ...... n solid organ transplantation.
@en
P2093
Bert van den Heuvel
Dirk Kuypers
Elena Levtchenko
Noël Knops
P356
10.1016/J.IJPHARM.2013.05.033
P407
P577
2013-05-24T00:00:00Z